Nanobiotix SA (EURONEXT:NANO) - Share price


Stock Report

Nanobiotix SA NANO

Last Price
10.23

Day Change
0.15|1.49%

As of 17/09/2021
17:35:43 CEST | EUR
Minimum 15 Minutes Delay.

Last Close10.08
Day Range10.02 - 10.36
Mkt Cap356.30Mil
52-Wk Range5.55 - 17.34
Yield %-
ISINFR0011341205
Volume69,087
P/E-
P/S10,000.00
P/CF-10.46

Share Price

Financials
201820192020
More ...
Income Statement
Revenue0.120.070.05
Operating Income-9.17-46.78-36.48
Net Income-30.35-50.92-33.59
Basic EPS-1.55-2.35-1.38
Avg. Diluted Shares Outstanding202224
Balance Sheet
Current Assets42.6546.13125.25
Non Current Assets3.5410.088.78
Total Assets46.2056.21134.03
Current Liabilities11.6014.3519.04
Total Liabilities31.9558.1163.56
Total Equity14.24-1.9170.47
Cash Flow
Operating Cash Flow-25.99-41.17-27.54
Capital Expenditure-0.51-1.44-0.11
Free Cash Flow-26.49-42.61-27.65

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

-
Key Stats
More ...
Price/Earning TTM-7.47
Price/Book8.47
Price/Sales TTM4,800.00
Rev Growth (3 year avg)-41.67
EPS Growth (3 year avg)-
Operating Margin % TTM-72,960.00
Net Margin % TTM-67,180.00
ROE TTM-97.99
Debt/Equity0.63
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.